Director, Financial Planning & Analysis
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant (Nasdaq: ROIV). As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.
The Role:
Reporting to the CFO, this position will have broad financial planning, management reporting, analysis, and business partnership responsibilities. The FP&A team works closely with the CFO and the Leadership Team to develop operating plans and multi-year strategic planning scenarios. This role will serve as the primary finance business partner for Research & Development, owning planning, forecasting, and reporting for the clinical development portfolio and partnering closely with the respective business leaders. The role is responsible for providing timely and accurate financial guidance and analytics to all levels of business partners to inform key decision-making in pursuit of the company’s financial and operational objectives.
As part of the broader financial team at Immunovant, this role will have opportunities for organic learning and development across multiple areas including clinical development and operations, CMC, Investor Relations, Accou
